Clinical Trials Browser

Phase 3 × Completed × elotuzumab × Clear all

NCT02726581 2023-03-27

CheckMate 602

Phase 3 Completed

170 enrolled 16 charts

Multiple Myeloma

NCT01335399 2022-09-30

ELOQUENT - 1

Phase 3 Completed

748 enrolled 15 charts

Multiple Myeloma

NCT01239797 2022-06-01

ELOQUENT - 2

Phase 3 Completed

646 enrolled 16 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT02495922 2021-09-10

GMMG-HD6

Phase 3 Completed

Multiple Myeloma